Selvaraj, B., Ganapathy, D., & Sekaran, S. Scleraxis (SCX): A novel therapeutic target in the malignant transformation of oral potentially malignant disorders. Elsevier.
Chicago Style (17th ed.) CitationSelvaraj, Bharathi, Dhanraj Ganapathy, and Saravanan Sekaran. Scleraxis (SCX): A Novel Therapeutic Target in the Malignant Transformation of Oral Potentially Malignant Disorders. Elsevier.
MLA (9th ed.) CitationSelvaraj, Bharathi, et al. Scleraxis (SCX): A Novel Therapeutic Target in the Malignant Transformation of Oral Potentially Malignant Disorders. Elsevier.
Warning: These citations may not always be 100% accurate.